Introduction
ERCP (Endoscopic Retrograde Cholangiopancreatography) is a specialized procedure that reaches the bile ducts and pancreatic duct — areas a standard endoscopy can't directly access — to both diagnose and, in the same session, treat blockages, stones, or narrowing. It's most commonly used for bile duct stones that have migrated from the gallbladder, but also plays a key role in diagnosing and treating pancreatic duct problems and certain tumors.
Is ERCP safe, and does it work?
Generally, yes on both counts — but it's worth understanding this is a more technically demanding procedure than a standard endoscopy, and the numbers reflect that. In large published series, the duct is successfully reached and treated in roughly 9 out of 10 procedures, including data from large Indian centers. On safety: about 1 in 10 patients experience some complication, most commonly a mild, temporary inflammation of the pancreas (pancreatitis) that typically resolves with monitoring and supportive care. Serious complications are less common. One thing genuinely worth knowing: how experienced the endoscopist and center are matters more for ERCP specifically than for many other procedures — well-established research shows higher-volume providers get better results with fewer complications. The section further down this page, ‘The evidence in more detail,’ has the specific data behind these figures.
What ERCP is used for
- Removing gallstones that have moved into the bile duct (see the Gallstones page)
- Relieving blockages in the bile duct caused by strictures or tumors
- Diagnosing and treating pancreatic duct problems, including some causes of pancreatitis (see the Pancreas Clinic page)
- Placing a stent to keep a narrowed duct open
- Taking tissue samples when a tumor is suspected
What to expect: before, during, and after
- Before: fasting for several hours, blood tests, and imaging to confirm ERCP is the right next step
- During: performed under sedation; a thin endoscope is passed through the mouth to the point where the bile and pancreatic ducts open into the small intestine, contrast dye is injected, and X-ray imaging guides treatment
- After: monitoring for several hours to watch for early signs of pancreatitis; most patients go home the same day or after a short observation period, though some cases require a longer stay
- Follow-up: depends on what was found and treated — your gastroenterologist will discuss next steps specific to your case
The evidence in more detail
This section is for anyone who wants the specific data behind the summary above — it's not necessary reading to understand what to expect from ERCP, but it's here for transparency.
A large single-center study from North India reviewing 3,544 ERCP procedures found successful cannulation of the duct in approximately 92–93% of cases, performed at a high-volume center by endoscopists with more than 1,000 career ERCP procedures each. A separate large series from North East India, reviewing 1,038 patients, found duct cannulation success of 89.2% and an overall procedural success rate of 82.66%, with post-procedure complications occurring in 9.2% of patients — pancreatitis being the most common. In general population data, successful cannulation is achieved in more than 85% of cases, with expert, high-volume endoscopists expected to achieve 95–100% technical success. Published research consistently links higher endoscopist and center case-volume to better cannulation success and lower complication rates, particularly for post-ERCP pancreatitis — see the Advanced Endoscopy Clinic page for more on why this matters.
ERCP care at KAGE
ERCP here is performed by our gastroenterologists in a high-volume therapeutic service led by Dr. Sreekanth Appasani, covering bile duct stones, strictures, and pancreas conditions including pancreatic duct stones. Where the papilla cannot be reached or cannulated, the same team completes drainage by EUS-guided biliary drainage in the same session instead of referring the patient on. To discuss an ERCP that has been advised, or one that has already failed elsewhere, book a consultation.
Frequently asked questions
Mild, temporary inflammation of the pancreas (pancreatitis), affecting roughly 1 in 10 patients in published data — usually managed with monitoring and supportive care rather than being a serious, lasting problem.
This varies depending on what's found and treated during the procedure, but many ERCPs are completed within 30 to 60 minutes.
In the small proportion of cases where ERCP isn't successful, alternative approaches — including surgical or other endoscopic options — are available, and your care team will discuss the right next step.
Coverage varies by policy; our team can help verify your specific coverage and explain costs during consultation.
Yes — this is one of ERCP's main advantages: diagnosis and treatment, such as stone removal, often happen in the same procedure.
It's a reasonable question to ask directly — research consistently shows that higher-volume, more experienced endoscopists achieve better outcomes with this specific procedure, more so than for many other endoscopic procedures.
In more difficult cases, additional specialized techniques can be used during the same procedure, or alternative approaches such as EUS-guided drainage may be considered — discussed with you based on your specific anatomy.
Most patients can resume eating once sedation has worn off and there are no concerning symptoms, typically the same day, guided by your care team's assessment.
No — ERCP examines the bile and pancreatic ducts via the mouth, while colonoscopy examines the colon via the rectum. They're different procedures for different purposes.
Yes, in select cases — performed by KAGE's pediatric gastroenterology team when clinically needed.
Book a consultation at KAGE
Speak to a KAGE gastroenterologist about your symptoms, your diagnosis, or a second opinion.